Analyzing charge variants in biologic drugs using advanced techniques
High-Resolution Native Capillary Zone Electrophoresis with Inline UV and Native Mass Spectrometry for Characterizing Charge Variants in Biologics
This study is working on a new tool to help scientists better understand different forms of biologic drugs, like monoclonal antibodies, to ensure they are safe and effective for patients.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Gmj Technologies, INC. NIH-funded |
| Lab location | 1 site (Everett, United States) |
| Project ID | NIH-11142793 on NIH RePORTER |
What this research studies
This research focuses on developing a high-resolution analytical tool to identify and characterize charge variants in biologic drugs, such as monoclonal antibodies and antibody-drug conjugates. By utilizing native capillary zone electrophoresis combined with inline UV and mass spectrometry, the project aims to improve the monitoring of product variants that may affect the safety and efficacy of these therapeutics. The methodology involves separating different charge variants to better understand their properties and potential impacts on patient treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include patients receiving biologic therapies for conditions such as cancer or autoimmune diseases.
Not a fit: Patients who are not receiving biologic therapies or those with conditions unrelated to the use of biologics may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance the safety and effectiveness of biologic therapies by ensuring that only the highest quality products are used in patient treatments.
How similar studies have performed: Other research has shown success in using advanced analytical techniques to characterize biologics, indicating that this approach is promising and builds on established methodologies.
Where this research is happening
Everett, United States
- Gmj Technologies, INC. — Everett, United States (Active)
Researchers
- Principal investigator: Dada, Oluwatosin — Gmj Technologies, INC.
- Study coordinator: Dada, Oluwatosin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.